ID

18477

Description

Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00173888

Link

https://clinicaltrials.gov/show/NCT00173888

Keywords

Versions (1)
  1. 11/7/16 11/7/16 -
Uploaded on

November 7, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-small Cell Lung Cancer NCT00173888

English

Eligibility Non-small Cell Lung Cancer NCT00173888

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologic or cytologic diagnosis of stage iiib/iv nsclc, no prior chemotherapy
Description

Non-Small Cell Lung Carcinoma | TNM clinical staging | Prior Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0007131
UMLS CUI [2]
C3258246
UMLS CUI [3]
C1514457
age > 18 years and < 75 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
who ps: 0,1
Description

WHO performance status scale

Data type

boolean

Alias
UMLS CUI [1]
C1298650
unidimensional or bi-dimensional measurable disease
Description

Measurable Disease Linear | Measurable Disease 2-Dimensional

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0205132
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C1705052
neutrophils > 1.5 109/l, platelets > 100 109/l, hemoglobin > 10g/dl, total bilirubin < 1.5 unl, ast (sgot) and alt (sgpt) < 2.5 unl, alkaline phosphatases < 5 unl; except in presence of only bone metastasis and in the absence of any liver disorders
Description

Neutrophil count | Platelet Count measurement | Hemoglobin | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement | Secondary malignant neoplasm of bone | Liver diseases Absent

Data type

boolean

Alias
UMLS CUI [1]
C0200633
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0019046
UMLS CUI [4]
C1278039
UMLS CUI [5]
C0201899
UMLS CUI [6]
C0201836
UMLS CUI [7]
C0201850
UMLS CUI [8]
C0153690
UMLS CUI [9,1]
C0023895
UMLS CUI [9,2]
C0332197
creatinine < 1 unl, and creatinine clearance should be > 60 ml/min.
Description

Creatinine measurement, serum | Creatinine clearance measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0373595
life expectancy > 12 weeks
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant, or lactating patients
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
known clinical brain or leptomeningeal involvement
Description

Metastatic malignant neoplasm to brain | Metastatic Malignant Neoplasm to the Leptomeninges

Data type

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C1704231
pre-existing motor or sensory neurotoxicity of a severity > grade 1 by ncic-ctg criteria
Description

Motor neuropathy Pre-existing | Sensory neuropathy Pre-existing | CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1,1]
C0235025
UMLS CUI [1,2]
C2347662
UMLS CUI [2,1]
C0151313
UMLS CUI [2,2]
C2347662
UMLS CUI [3]
C1516728
chf, angina or arrhythmias
Description

Congestive heart failure | Angina Pectoris | Cardiac Arrhythmia

Data type

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0002962
UMLS CUI [3]
C0003811
history of significant neurological or psychiatric disorders
Description

nervous system disorder Significant | Mental disorders Significant

Data type

boolean

Alias
UMLS CUI [1,1]
C0027765
UMLS CUI [1,2]
C0750502
UMLS CUI [2,1]
C0004936
UMLS CUI [2,2]
C0750502
active uncontrolled infection
Description

Communicable Disease Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
contraindication for the use of corticosteroids
Description

Medical contraindication Adrenal Cortex Hormones

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0001617
concurrent treatment with other experimental drugs within 30 days prior to study entry
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
concurrent treatment with any other anti-cancer therapy
Description

cancer treatment

Data type

boolean

Alias
UMLS CUI [1]
C0920425
Back to the top of the page

Similar models

Eligibility Non-small Cell Lung Cancer NCT00173888

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma | TNM clinical staging | Prior Chemotherapy
Item
histologic or cytologic diagnosis of stage iiib/iv nsclc, no prior chemotherapy
boolean
C0007131 (UMLS CUI [1])
C3258246 (UMLS CUI [2])
C1514457 (UMLS CUI [3])
Age
Item
age > 18 years and < 75 years
boolean
C0001779 (UMLS CUI [1])
WHO performance status scale
Item
who ps: 0,1
boolean
C1298650 (UMLS CUI [1])
Measurable Disease Linear | Measurable Disease 2-Dimensional
Item
unidimensional or bi-dimensional measurable disease
boolean
C1513041 (UMLS CUI [1,1])
C0205132 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C1705052 (UMLS CUI [2,2])
Neutrophil count | Platelet Count measurement | Hemoglobin | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement | Secondary malignant neoplasm of bone | Liver diseases Absent
Item
neutrophils > 1.5 109/l, platelets > 100 109/l, hemoglobin > 10g/dl, total bilirubin < 1.5 unl, ast (sgot) and alt (sgpt) < 2.5 unl, alkaline phosphatases < 5 unl; except in presence of only bone metastasis and in the absence of any liver disorders
boolean
C0200633 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0019046 (UMLS CUI [3])
C1278039 (UMLS CUI [4])
C0201899 (UMLS CUI [5])
C0201836 (UMLS CUI [6])
C0201850 (UMLS CUI [7])
C0153690 (UMLS CUI [8])
C0023895 (UMLS CUI [9,1])
C0332197 (UMLS CUI [9,2])
Creatinine measurement, serum | Creatinine clearance measurement
Item
creatinine < 1 unl, and creatinine clearance should be > 60 ml/min.
boolean
C0201976 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Life Expectancy
Item
life expectancy > 12 weeks
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant, or lactating patients
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Metastatic malignant neoplasm to brain | Metastatic Malignant Neoplasm to the Leptomeninges
Item
known clinical brain or leptomeningeal involvement
boolean
C0220650 (UMLS CUI [1])
C1704231 (UMLS CUI [2])
Motor neuropathy Pre-existing | Sensory neuropathy Pre-existing | CTCAE Grades
Item
pre-existing motor or sensory neurotoxicity of a severity > grade 1 by ncic-ctg criteria
boolean
C0235025 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C0151313 (UMLS CUI [2,1])
C2347662 (UMLS CUI [2,2])
C1516728 (UMLS CUI [3])
Congestive heart failure | Angina Pectoris | Cardiac Arrhythmia
Item
chf, angina or arrhythmias
boolean
C0018802 (UMLS CUI [1])
C0002962 (UMLS CUI [2])
C0003811 (UMLS CUI [3])
nervous system disorder Significant | Mental disorders Significant
Item
history of significant neurological or psychiatric disorders
boolean
C0027765 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0004936 (UMLS CUI [2,1])
C0750502 (UMLS CUI [2,2])
Communicable Disease Uncontrolled
Item
active uncontrolled infection
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Medical contraindication Adrenal Cortex Hormones
Item
contraindication for the use of corticosteroids
boolean
C1301624 (UMLS CUI [1,1])
C0001617 (UMLS CUI [1,2])
Investigational New Drugs
Item
concurrent treatment with other experimental drugs within 30 days prior to study entry
boolean
C0013230 (UMLS CUI [1])
cancer treatment
Item
concurrent treatment with any other anti-cancer therapy
boolean
C0920425 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial